维普中文期刊产品整合服务
55篇 您的检索式:作者名="CHAWLA SP"
    题名 作者 年代 出处 被引量
1Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients w ith advanced bone and soft tissue sarcomas显示文摘Chawla SP Staddon AP Baker LH 2012Journal of Clinical Oncology2012,30,1:1
2Gelation of proteins from washed muscle of Threadfin Bream (Nemipterusjaponicus) under mild acidic conditions显示文摘Chawla SP Venugopal V Nair PM 1996Journal of Food Science1996,61,2:1
3Trabectedin (Tr) in the treatment of advanced uterine leiomyosarcomas (U- LMS) :Results of a pooled analysis of five single - agent phase Ⅱ studies using the recommended dose显示文摘Judson IR Blay J Chawla SP 2010J Clin Oncol2010,28,10:1
4Phase I and Ⅱ studies of intravenous Rexin-G as monotherapy for stage IVb gem- citabine-resistant pancreatic cancer显示文摘BRUCKNER H CHAWLA SP CHUA CS 2010J Clin Oncol2010,28,15:1
5Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide:results of a randomized phase Ⅱ study of two different schedules显示文摘Demetri GD Chawla SP von MM 0,,:1
6A phase v, randomized, controlled trial of palifosfamide plus doxorubicin versus doxorubicin in patients with soft tissue sarcoma (PICASSO) 显示文摘Verschraegen CF Chawla SP Mira MM 2010J Clin Oncol2010,28,10:1
7Phase I/Ⅱ study of TH -302 combined with doxorubicin in soft tissue sarcoma显示文摘Cranmer LD Chawla SP Rushing DA 2010J Clin Onco12010,28,10:1
8Pazopanib for metastatic soft-tissue sarcoma(PALETTE):a randomised,double-blind,placebo-controlled phase 3 trial显示文摘van der Graaf WT Blay JY Chawla SP 0,,:1
9Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial显示文摘van der Graaf WT Blay JY Chawla SP 2012Lancet2012,379,18:1
10Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas显示文摘Chawla SP Staddon AP Baker LH 0,,:1
11Results of the phase III,placebo-controlled trial(SUCCEED)evaluating the mTOR inhibitor ridaforolimus(R)as maintenance therapy in advanced sarcoma patients(pts)fol owing clinical benefit from prior standard cytotoxic chemotherapy(CT)显示文摘Chawla SP Blessing J Ray-Coquard I 0,,:1
12Safe and shelf-stable natural casing using hurdle technology显示文摘Chawla SP Chander R Sharma A 2006Food Control2006,17,:1
13A phase I/Ⅱ study of intravenous Rexin-G and Reximmune-C for cancer immunotherapy: The GeneVieve protocol 显示文摘Ignacio JG Chawla SP Manalo RE 2010J Clin Oncol2010,28,15:1
14Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting 显示文摘Chawla SP Grunberg SM Gralla RJ 2003Cancer2003,97,9:1
15Establishing the dose of the oral NKI antagonist aprepitant for the prevention of chemo-therapy-induced nausea and vomiting显示文摘Chawla SP Grnnberg SM Gralla RJ 2003Cancer2003,97,9:1
16Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase Ⅱ study of two different schedules 显示文摘Demetri GD Chawla SP von Mehren M 2009J Clin Oncol2009,27,25:1
17Pazopanib for metastatic soft-tissue sarcoma (PALETI'E): a randomised, double-blind, placebo-controlled phase 3 trial显示文摘van der Graaf WT Blay JY Chawla SP 2012Lancet2012,379,9829:1
18Establishing the dose of the oral NK-1 antagonist Aprepitant forchemotherapy-induced nausea and vomiting显示文摘Chawla SP Grunberg SM Gralla R J 2003Cancer2003,97,9:1
19Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules显示文摘Demetri GD Chawla SP von Mehren M et a! 2009J Clin Oncol2009,27,25:1
20Antioxidant potential of maiIlard reaction products formed by irradiation of chitosan-glu- cose solution 显示文摘Rao MS Chawla SP Chander R 2011Carbohydrate Polymers2011,83,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费